Madrigal Pharmaceuticals
MDGL
MDGL
132 hedge funds and large institutions have $1.36B invested in Madrigal Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 46 increasing their positions, 41 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
3.97% more ownership
Funds ownership: 75.37% → 79.34% (+4%)
1% less capital invested
Capital invested by funds: $1.38B → $1.36B (-$17.3M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
132
Holding in Top 10
2
Calls
$9.07M
Puts
$4.18M
Top Buyers
| 1 | +$37.2M | |
| 2 | +$31.9M | |
| 3 | +$23.6M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$14M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13.6M |
Top Sellers
| 1 | -$25.3M | |
| 2 | -$25M | |
| 3 | -$13.2M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$6.99M |
| 5 |
Goldman Sachs
New York
|
-$5.2M |